Hawk Kim
Hematology Hawk Kim Favorite Doctor
  • SpecialtyLeukemia, bone marrow failure
  • Site
Appointment
Schedule
의료진 진료일정
Week M T W T F S
AM     Present   Present  
PM     Present      
Clinical Interests

Acute myeloid leukemia
Chronic myeloid leukemia
Myelodysplastic syndromes
Aplastic anemia
Anemia
Thrombocytopenia
Leukopenia
Splenomegaly
Rare blood diseses

Education
Education
1995 Hanyang University College of Medicine, MD
1999 Hanyang University Graduate College of Medicine, M.S
2007 Ulsan University Graduate College of Medicine, Ph.D.
Career
Career
1995 Hanyang University Hospital, Intern
1996 Department of Internal Medicine, Hanyang University Hospital, Resident
2000 Army Medical Center Hospital, Medical officer
2003 Asan Medical Center, Clinical Instructor
2005 Ulsan University Hospital, Professor
2017~ Gachon University Gil Medical Center, Professor
More
Community
Community
More
Training
Training
2008 M. D. Anderson Cancer Center
License
License
1995 Medical License
2000 Internal Medicine Specialist
2006 Hematology Oncology Specialist
Hawk Kim
Paper
Paper
2019 Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukemia in the chronic phase (RERISE).
2019 Age and remission induction therapy for acute myeloid leukemia (AML): from Korean AML registry
2019 Prospective randomized trial comparing two doses of rabbit antithymocyte globulin in patients with severe aplastic anemia.
2019 Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome.
2019 Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia (AML) in older adults and the role of a mini nutritional assessment short form (MNA-SF).
More